R. Douglas Norby, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 30,000 shares at $85.01 ($2.6M) on 2012-03-09, disclosed to the SEC on 2012-03-12.
Scheduled sale ($2.6M) by Director.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.00 | 1,700 | $145K | 5.7% |
| 2 | $85.01 | 28,300 | $2.4M | 94.3% |
| Total | $85.01 avg | 30,000 | $2.6M | 100% |
| Filing → |
| ALXN | SELL | 2013-05-23 | $4.1M | — | Filing → |
| ALXN | SELL | 2012-12-12 | $2.0M | — | Filing → |
| ALXN | SELL | 2011-10-31 | $3.1M | — | Filing → |